These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27462690)

  • 1. Helicobacter pylori: a pathogenic threat to the gastric mucosal barrier.
    Oluwole FS
    Afr J Med Med Sci; 2015 Dec; 44(4):289-96. PubMed ID: 27462690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-standing gastric mucosal barrier dysfunction in Helicobacter pylori-induced gastritis in mongolian gerbils.
    Sun YQ; Söderholm JD; Petersson F; Borch K
    Helicobacter; 2004 Jun; 9(3):217-27. PubMed ID: 15165257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Helicobacter pylori in peptic ulcer and gastric cancer].
    Matsukura N; Onda M; Yamashita K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of heat shock proteins in gastric inflammation and ulcer healing.
    Choi SR; Lee SA; Kim YJ; Ok CY; Lee HJ; Hahm KB
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():5-17. PubMed ID: 20388941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term consequences of Helicobacter pylori eradication.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1994; 205():38-44. PubMed ID: 7863240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
    Joh T; Sasaki M; Kataoka H; Tanida S; Itoh K; Kondo Y; Ogasawara N; Oshima T; Okada N; Ohara H; Sano H; Nakao H; Sobue S; Itoh M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1344-51. PubMed ID: 16105119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori in ulcerogenesis.
    Lin SK; Lambert JR
    Scand J Gastroenterol Suppl; 1995; 210():64-9. PubMed ID: 8578211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
    Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
    Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma.
    Graham DY
    Prev Med; 1994 Sep; 23(5):712-6. PubMed ID: 7845945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal inflammation and disease in Helicobacter pylori infection.
    Veenendaal RA; Götz JM; Lamers CB
    Scand J Gastroenterol Suppl; 1996; 218():86-91. PubMed ID: 8865456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection.
    Miyake K; Tatsuguchi A; Suzuki K; Ueki N; Shinji Y; Kusunoki M; Iizumi T; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Tsukui T; Sakamoto C
    Dig Liver Dis; 2005 Jun; 37(6):394-401. PubMed ID: 15893277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eradication of Helicobacter pylori in Japan].
    Kamimoto H; Fukuda Y; Tamura K; Shimoyama T
    Nihon Rinsho; 1999 Jun; 57(6):1435-41. PubMed ID: 10391015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric angiogenesis and Helicobacter pylori infection.
    Pousa ID; Gisbert JP
    Rev Esp Enferm Dig; 2006 Jul; 98(7):527-41. PubMed ID: 17022702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is new related to Helicobacter pylori infection in children and teenagers?
    Kato S; Sherman PM
    Arch Pediatr Adolesc Med; 2005 May; 159(5):415-21. PubMed ID: 15867113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Helicobacter pylori in peptic ulcer disease.
    Partipilo ML; Woster PS
    Pharmacotherapy; 1993; 13(4):330-9. PubMed ID: 8361859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Helicobacter pylori in peptic ulcer disease.
    O'Connor HJ
    Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori. Its role in the pathogenesis of peptic ulcer disease in a new animal model.
    Ross JS; Bui HX; del Rosario A; Sonbati H; George M; Lee CY
    Am J Pathol; 1992 Sep; 141(3):721-7. PubMed ID: 1519673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease.
    Liu Y; Akiyama J; Graham DY
    Minerva Gastroenterol Dietol; 2006 Sep; 52(3):235-48. PubMed ID: 16971868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.